Caris Life Sciences
€22.20
37
-€2.00-8.26%Friday 16:30
Statistics
Day High
23.8
Day Low
22.8
52W High
32.2
52W Low
22.2
Volume
-
Avg. Volume
-
Mkt Cap
6.27B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 4Expected
Q2 2026
Q3 2026
0
0.01
0.03
0.04
Expected EPS
0.02504596112
Actual EPS
0.044504
Financials
-66.25%Profit Margin
Unprofitable700.01MRevenue
-463.78MNet Income
Analyst Ratings
$25.04Average Price Target
The highest estimate is 28.83.
From 8 ratings within the last 6 months. This is not an investment recommendation.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy 63%
Hold 38%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 49J.XETRA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Show More
CEO
David Dean Halbert
Employees
1846
Country
United States
ISIN
US1421521071
WKN
000A41A14
Listings
0 Comments
Share your thoughts
FAQs
What is Caris Life Sciences stock price today?▼
The current price of 49J.XETRA is €22.20 EUR — it has decreased by -8.26% in the past 24 hours. Watch Caris Life Sciences stock price performance more closely on the chart.
What is Caris Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange Caris Life Sciences stocks are traded under the ticker 49J.XETRA.
What is Caris Life Sciences market cap?▼
Today Caris Life Sciences has the market capitalization of 6.27B
When is the next Caris Life Sciences earnings date?▼
Caris Life Sciences is going to release the next earnings report on March 4, 2027.
What were Caris Life Sciences earnings last quarter?▼
49J.XETRA earnings for the last quarter are 0.04 EUR per share, whereas the estimation was 0.03 EUR resulting in a +77.69% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Caris Life Sciences revenue for the last year?▼
Caris Life Sciences revenue for the last year amounts to 700.01M EUR.
What is Caris Life Sciences net income for the last year?▼
49J.XETRA net income for the last year is -463.78M EUR.
How many employees does Caris Life Sciences have?▼
As of November 8, 2026, the company has 1,846 employees.
In which sector is Caris Life Sciences located?▼
Caris Life Sciences operates in the Health & Wellness sector.
When did Caris Life Sciences complete a stock split?▼
Caris Life Sciences has not had any recent stock splits.
Where is Caris Life Sciences headquartered?▼
Caris Life Sciences is headquartered in IRVING, United States.